Kathy Whitney Archive — Page 16 of 25

Metallic medical device with a large central tube, side connector, purple handle, and attached white hose, photographed on a white reflective surface.
October 21, 2015

Vanderbilt first in Tennessee to implant novel heart support device

Head-and-shoulders portrait of Ashish S. Shah, M.D., wearing glasses, a white medical coat, shirt, and tie against a neutral background.
October 15, 2015

Shah named to direct VHVI’s heart transplant program

Ashish Shah, M.D., has joined Vanderbilt Heart and Vascular Institute (VHVI) as director of Heart Transplant and Mechanical Circulatory Support.

October 15, 2015

VUMC set to host inaugural Global Cardio-Oncology Summit

Vanderbilt University Medical Center is hosting the first Global Cardio-Oncology Summit on Oct. 15-16, at the Hilton Nashville. The summit models a leading edge, interdisciplinary approach to cardio-oncology.

depressed man
October 8, 2015

Depression poses heart risk for HIV patients: study

The first study to suggest that major depressive disorder (MDD) is an independent risk factor for heart failure in HIV-positive adults has been published in Circulation.

Four physicians, three in white coats and one in a dark suit, pose outdoors in front of a medical building; the coats include partially visible names and specialty text.
September 24, 2015

Cancer therapies’ impact on heart, kidneys explored

Vanderbilt is embarking on a multi-disciplinary approach to understand how promising cancer treatments, specifically certain kinase inhibitors, affect the heart and kidneys.

Close-up of a healthcare worker using a manual blood pressure cuff and stethoscope to measure a seated person’s arm, with an analog gauge and computer keyboard in the background.
September 17, 2015

Study shows lower systolic BP targets reduce death risk

The initial results of a landmark clinical trial sponsored by the National Institutes of Health (NIH) indicate lowering systolic blood pressure below a commonly recommended target significantly reduces rates of cardiovascular events and lowers risk of death in a group of adults 50 years and older.